Elliniki Ogkologiki Erevnitiki Omada

Elliniki Ogkologiki Erevnitiki Omada is an organisation in Athens, Greece that has taken part in 2 EU-funded projects since 2024, receiving €753k in EU funding.

EU funding received€753k
EU projects2
As coordinator0
Running now2
First EU project2024
Latest project2027
CountryGreece
EU registration (PIC)919318374
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Elliniki Ogkologiki Erevnitiki Omada's own share of each project, not the project's full budget.

  • Horizon Europe€753k · 2 projects

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • CTC4CLINICPartner

    EXPLORING THE MECHANISM OF METASTASIS/DEVELOPMENT OF NEW TESTS TO ENROLL CIRCULATING TUMOR CELLS (CTCs) INTO CLINICAL PRACTICE

    Horizon Europe · 2027–2030 · Project on CORDIS ↗

    €65ktheir share
  • MULTIRPartner

    MULti-Tumour based prediction and manipulation of Immune Response

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €688ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • analytical chemistry
  • artificial intelligence
  • biochemistry
  • bladder cancer
  • drug discovery
  • immunology
  • pancreatic cancer
  • social sciences

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime